Aktie 3218 UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Universal Vision Biotechnology Co., Ltd.

Aktien

3218

TW0003218004

3218

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
256 TWD -0.97% Intraday Chart für Universal Vision Biotechnology Co., Ltd. +8.47% -7.58%
14.03. Universal Vision Biotechnology Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Universal Vision Biotechnology Co., Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Health Care Down on Mixed Earnings Prospects - Health Care Roundup
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes
Universal Vision Biotechnology : Clarification of mass media reporting
Universal Vision Biotechnology : Change of the principal financial and accounting officer of the Company
Universal Vision Biotechnology Co., Ltd. Announces Change of the Principal Financial and Accounting Officer
Universal Vision Biotechnology : The Company is invited to Citi's investor conference call for 1H2022 earnings
Universal Vision Biotechnology : Announcement of 2Q2022 consolidated financial reports approved by the Board of Directors
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Universal Vision Biotechnology : Change of the principal financial and accounting officer of the Company
Universal Vision Biotechnology : Announcement of important resolutions of the Company's 2022 General Shareholders'Meeting
Universal Vision Biotechnology : The Company is invited to Fubon Securities’ 2022Q2 Investment Forum Online
Universal Vision Biotechnology : The Company is invited to Yuanta Securities’ 2022Q2 Investment Forum Online
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 3218 Aktie
  4. Nachrichten Universal Vision Biotechnology Co., Ltd.
  5. Andere Sprachen